Indeed, the pharmaceutical industry does invest considerably in research, but it's also worth noting that a lot of its spending goes towards marketing rather than research and development. Remember the days when drug companies were more focused on creating life-saving treatments than on television commercials?
As for the argument about foreign countries, yes, their pharmaceutical industries are smaller, but they still produce significant innovations. The discovery of Insulin by Canadian scientists or the development of the AstraZeneca vaccine in the UK are examples of this.
Your concern about the potential complexity of a tiered approach is valid. However, the current system is already complex and, some might argue, unfair. It's like trying to navigate through a forest without a map - daunting, isn't it? Maybe it's time to blaze a new trail.
I agree with your point about increasing transparency. It reminds me of those clear, simple ingredient lists we see on food packages. Shouldn't we have the same for our medications?
But how about this for a thought - could we possibly combine these ideas? Implement a tiered approach, increase transparency, and still encourage innovation? Maybe the key is in finding a balance that suits all parties involved. What are your thoughts?
Be the first to reply to this disagreement.